Neurones Valuation
| NRO Stock | EUR 49.55 0.40 0.81% |
At this time, the firm appears to be undervalued. Neurones secures a last-minute Real Value of €55.15 per share. The latest price of the firm is €49.55. Our model forecasts the value of Neurones from analyzing the firm fundamentals such as Profit Margin of 0.07 %, return on equity of 0.14, and Current Valuation of 735.59 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Neurones' price fluctuation is very steady at this time. Calculation of the real value of Neurones is based on 3 months time horizon. Increasing Neurones' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Neurones is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Neurones Stock. However, Neurones' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 49.55 | Real 55.15 | Hype 49.55 |
The real value of Neurones Stock, also known as its intrinsic value, is the underlying worth of Neurones Company, which is reflected in its stock price. It is based on Neurones' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Neurones' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Neurones helps investors to forecast how Neurones stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neurones more accurately as focusing exclusively on Neurones' fundamentals will not take into account other important factors: Neurones Total Value Analysis
Neurones is now estimated to have takeover price of 735.59 M with market capitalization of 1.01 B, debt of 27.82 M, and cash on hands of 169.6 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Neurones fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
735.59 M | 1.01 B | 27.82 M | 169.6 M |
Neurones Investor Information
About 71.0% of the company outstanding shares are owned by corporate insiders. The book value of Neurones was now reported as 12.78. The company last dividend was issued on the 8th of June 2022. Based on the key indicators related to Neurones' liquidity, profitability, solvency, and operating efficiency, Neurones is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Neurones Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Neurones has an asset utilization ratio of 102.12 percent. This suggests that the Company is making €1.02 for each dollar of assets. An increasing asset utilization means that Neurones is more efficient with each dollar of assets it utilizes for everyday operations.Neurones Ownership Allocation
Neurones maintains a total of 24.22 Million outstanding shares. Neurones secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 70.71 % of Neurones outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Neurones Profitability Analysis
The company reported the revenue of 579.88 M. Net Income was 37.71 M with profit before overhead, payroll, taxes, and interest of 256.58 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Neurones' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Neurones and how it compares across the competition.
About Neurones Valuation
The stock valuation mechanism determines Neurones' current worth on a weekly basis. Our valuation model uses a comparative analysis of Neurones. We calculate exposure to Neurones's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Neurones's related companies.Neurones S.A., an information technology services company, provides infrastructure, application, and consulting services in France and internationally. Neurones S.A. was founded in 1985 and is headquartered in Nanterre, France. NEURONES operates under Information Technology Services classification in France and is traded on Paris Stock Exchange. It employs 5160 people.
8 Steps to conduct Neurones' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Neurones' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Neurones' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Neurones' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Neurones' revenue streams: Identify Neurones' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Neurones' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Neurones' growth potential: Evaluate Neurones' management, business model, and growth potential.
- Determine Neurones' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Neurones' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Neurones Stock analysis
When running Neurones' price analysis, check to measure Neurones' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurones is operating at the current time. Most of Neurones' value examination focuses on studying past and present price action to predict the probability of Neurones' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurones' price. Additionally, you may evaluate how the addition of Neurones to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |